These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
564 related items for PubMed ID: 26701851
1. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer. Mansour MA, Hyodo T, Akter KA, Kokuryo T, Uehara K, Nagino M, Senga T. Oncotarget; 2016 Jan 26; 7(4):4993-5006. PubMed ID: 26701851 [Abstract] [Full Text] [Related]
2. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling. Mansour MA, Hyodo T, Ito S, Kurita K, Kokuryo T, Uehara K, Nagino M, Takahashi M, Hamaguchi M, Senga T. FEBS J; 2015 Apr 26; 282(8):1394-405. PubMed ID: 25662172 [Abstract] [Full Text] [Related]
3. Expression of SATB1 promotes the growth and metastasis of colorectal cancer. Zhang Y, Tian X, Ji H, Guan X, Xu W, Dong B, Zhao M, Wei M, Ye C, Sun Y, Yuan X, Yang C, Hao C. PLoS One; 2014 Apr 26; 9(6):e100413. PubMed ID: 24971456 [Abstract] [Full Text] [Related]
4. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation. Chen Z, Li Z, Li W, Zong Y, Zhu Y, Miao Y, Xu Z. Dig Dis Sci; 2015 Nov 26; 60(11):3304-17. PubMed ID: 26108419 [Abstract] [Full Text] [Related]
5. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells. Li Y, Liu YH, Hu YY, Chen L, Li JM. World J Gastroenterol; 2016 Oct 14; 22(38):8528-8539. PubMed ID: 27784965 [Abstract] [Full Text] [Related]
6. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression. Cheng Q, Yuan F, Lu F, Zhang B, Chen T, Chen X, Cheng Y, Li N, Ma L, Tong T. Oncotarget; 2015 Mar 10; 6(7):4733-44. PubMed ID: 25749381 [Abstract] [Full Text] [Related]
7. SATB1 and 2 in colorectal cancer. Brocato J, Costa M. Carcinogenesis; 2015 Feb 10; 36(2):186-91. PubMed ID: 25543122 [Abstract] [Full Text] [Related]
8. SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo. Zhang J, Zhang B, Zhang X, Sun Y, Wei X, McNutt MA, Lu S, Liu Y, Zhang D, Wang M, Lin Z, Niu N. PLoS One; 2013 Feb 10; 8(1):e47902. PubMed ID: 23326301 [Abstract] [Full Text] [Related]
9. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk. Ye Y, Xiao L, Wang SJ, Yue W, Yin QS, Sun MY, Xia W, Shao ZY, Zhang H. Oncotarget; 2016 Jan 26; 7(4):3921-33. PubMed ID: 26646797 [Abstract] [Full Text] [Related]
14. miR‑3666 suppresses cellular proliferation and invasion in colorectal cancer by targeting SATB2. Yang D, Li R, Xia J, Li W, Zhou H. Mol Med Rep; 2018 Dec 26; 18(6):4847-4854. PubMed ID: 30320357 [Abstract] [Full Text] [Related]
20. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer. Toiyama Y, Yasuda H, Saigusa S, Tanaka K, Inoue Y, Goel A, Kusunoki M. Carcinogenesis; 2013 Nov 26; 34(11):2548-57. PubMed ID: 24001454 [Abstract] [Full Text] [Related] Page: [Next] [New Search]